Results 1 to 10 of about 4,947,330 (332)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently needed.
Talia Greenstein   +5 more
doaj   +3 more sources

The Role of Fatty Acid Metabolism in Drug Tolerance of Mycobacterium tuberculosis [PDF]

open access: yesmBio, 2022
Mycobacterium tuberculosis can cocatabolize a range of carbon sources. Fatty acids are among the carbons available inside the host’s macrophages. Here, we investigated the metabolic changes of the fatty acid-induced dormancy-like state of M. tuberculosis
Camila G. Quinonez   +7 more
doaj   +3 more sources

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Suboptimal efficacy of the current antibiotic regimens and frequent emergence of antibiotic-resistant Mycobacterium tuberculosis (Mtb), an etiological agent of tuberculosis (TB), render TB the world’s deadliest infectious disease before the COVID-19 ...
Hyungjin Eoh   +4 more
doaj   +3 more sources

Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans. [PDF]

open access: goldmBio, 2021
Candida albicans is a prevalent human fungal commensal and also a pathogen that causes life-threatening systemic infections. Treatment failures are frequent because few therapeutic antifungal drug classes are available and because drug resistance and ...
Yang F   +7 more
europepmc   +3 more sources

Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance. [PDF]

open access: goldNat Commun, 2022
Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-genomic processes. 5-fluorouracil (5-FU), the most widely used chemotherapy in oncology is associated with resistance.
Therizols G   +31 more
europepmc   +4 more sources

Extreme Drug Tolerance of Mycobacterium abscessus “Persisters” [PDF]

open access: yesFrontiers in Microbiology, 2020
Persistence of infection despite extensive chemotherapy with antibiotics displaying low MICs is a hallmark of lung disease caused by Mycobacterium abscessus (Mab). Thus, the classical MIC assay is a poor predictor of clinical outcome.
Yee-Kuen Yam   +5 more
doaj   +3 more sources

The proteasome regulator Rpn4 controls antifungal drug tolerance by coupling protein homeostasis with metabolic responses to drug stress. [PDF]

open access: yesPLoS Pathog, 2023
Fungal pathogens overcome antifungal drug therapy by classic resistance mechanisms, such as increased efflux or changes to the drug target. However, even when a fungal strain is susceptible, trailing or persistent microbial growth in the presence of an ...
Yau KPS   +7 more
europepmc   +2 more sources

Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance. [PDF]

open access: yesFront Cell Infect Microbiol, 2022
Treatment of Mycobacterium tuberculosis (Mtb) infections is particularly arduous. One challenge to effectively treating tuberculosis is that drug efficacy in vivo often fails to match drug efficacy in vitro.
Samuels AN   +4 more
europepmc   +2 more sources

Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse. [PDF]

open access: yesJ Clin Invest, 2022
Although first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy is effective for treating EGFR-mutant non–small cell lung cancer (NSCLC), it is now understood that drug-tolerant persister (DTP) cells escaping from ...
Nie M   +12 more
europepmc   +2 more sources

Origin and Dynamics of Mycobacterium tuberculosis Subpopulations That Predictably Generate Drug Tolerance and Resistance. [PDF]

open access: yesmBio, 2022
Tuberculosis is unusual among bacterial diseases in that treatments which can rapidly resolve symptoms do not predictably lead to a durable cure unless treatment is continued for months after all clinical and microbiological signs of disease have been ...
Sebastian J   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy